Ko-Hsiu Lu

10PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersObstetrics and gynaecologyMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 08, 2026
Discontinuing Long-Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?

|Apr 01, 2026
Denosumab Offers Relatively Lower Initial Protection Against Osteoporotic Vertebral Fractures in Treatment-Naive Patients Compared With Zoledronate.

Ko-Hsiu Lu, Shiow-Ing Wang, Shun-Fa Yang

|Jan 04, 2026
Real-world evidence indicates romosozumab use is associated with a greater reduction in osteoporotic fractures than PTH (1-34) analogs in women.

Ko-Hsiu Lu, Shiow-Ing Wang, Shun-Fa Yang

|Jun 24, 2022
HO-3867 Induces Apoptosis via the JNK Signaling Pathway in Human Osteosarcoma Cells.

Peace Wun-Ang Lu, Chia-Hsuan Chou, Jia-Sin Yang

|Jan 11, 2022
Niclosamide Suppresses Migration and Invasion of Human Osteosarcoma Cells by Repressing TGFBI Expression via the ERK Signaling Pathway.

Liang-Tsai Yeh, Chiao-Wen Lin, Ko-Hsiu Lu

|Jul 02, 2021
Lipocalin-2 Inhibits Osteosarcoma Cell Metastasis by Suppressing MET Expression via the MEK-ERK Pathway.

Ko-Hsiu Lu, Jia-Sin Yang, Yi-Hsien Hsieh

Pageof 2

Frequent Collaborators

9 joint publications

Shun-Fa Yang

5 joint publications

Yi-Hsien Hsieh

1 joint publications

Heng-Hsiung Wu

1 joint publications

Chung-Jung Liu